The Food and Drug Administration is beefing up its oversight of pharmacies that create custom drugs in response to a 2012 meningitis outbreak linked to tainted medicines that left 64 people dead.
The FDA released regulations Tuesday for compounding pharmacies, which work with physicians to create specific drugs for individual patients, rather than mass producing pharmaceuticals for the public.
